whytestocks
4 years ago
News; $ALGN DPW Holdings' Gresham Worldwide Business Announces Development Agreement with Global Medical Device Company
NEWPORT BEACH, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (“ DPW ,” or the “ Company ”) announced that its global defense and technology business, Gresham Worldwide, Inc. (“ Gre...
In case you are interested ALGN - DPW Holdings' Gresham Worldwide Business Announces Development Agreement with Global Medical Device Company
whytestocks
4 years ago
News: $ALGN Everything You Need to Know About Clear Teeth Aligners
Rightly or wrongly, Americans perceive people with straight teeth as more attractive, successful, and employable than those without, according to studies. Hence, an investment into treatments for teeth straightening has the potential to really pay off in the long run. One such treatment that has...
Got this from ALGN - Everything You Need to Know About Clear Teeth Aligners
ITMS
5 years ago
Align Technology $ALGN Has Been Hammered, Here Is The Trade Level
Late last month, leading clear aligner therapy stock, Align Technology (NASDAQ:ALGN), was hammered lower after reporting earnings that disappointed the street. The stock actually peaked out in September 2018 at $398.87 a share. It then made a lower high on the daily chart on May 15, 2019 at $334.64 a share. The stock is currently trading at $176.00 a share, but it remains in a weak technical position on the charts. The stock is now trading below its 200-week moving average which is a near term negative for the stock price. While the stock is currently oversold it is still signaling further downside before a solid bottom is formed. The one level that has caught my eye in the stock is around the $138.00 area. This level is where the stock actually broke out in May 2017. As you all know by now, I really like pullbacks into past break-out levels as institutions will generally support the equity around this area. Please note, ALGN stock generally trades less than 1 million shares a day, so it is always vulnerable to overshoot levels.
Nicholas Santiago
InTheMoneyStocks
TREND1
6 years ago
CHARTIST HOTLINE
Wednesday, October 10, 2018
Whenever the Dow falls in excess of 1%, we update this hotline. Stocks were sharply lower all across the board in today’s session with the Dow dropping a resounding 831 points -3.15%. The S&P 500 fell 94.61 -3.28%, recording its worst single session loss since February 8th. The Actual Cash Account lost $38,911 -2.79%.
Declining stocks led by close to 8 to 1 on the NYSE and 7 to 1 on the Nasdaq. It’s not a pretty sight. In the Traders Portfolio there were two winners versus 31 losers. With Lululemon -5.71%, Align Technology, -5.78%, and Square -7.75% le leading on the downside. Traders should be aware that Align Technology (ALGN) and PayPal (PYPL) closed below their mental stops today and should now be sold. Several other traders’ recommendations are extremely close to their mental stops. So, in the absence of a sharp rally tomorrow, we can expect several violations of the respective mental stops.
Most indices close at their lows of the day with our overbought/oversold indicator hitting a heavily oversold -4.59%, which is the heaviest oversold reading since last February. We should be getting a technical bounce in the next day or two. Our models are still positive, and our advice for long term investors who are acting in sync with our Real Money Accounts is to continue to maintain all positions. Traders are advised to monitor the mental stops on a daily basis.
Our next regular hotline is scheduled for Thursday, October 11th, 3:00 p.m., West Coast Time
ITMS
7 years ago
Align Technology $ALGN Gets Slammed After Downgrade, Watch This Support Level
Align Technology Inc (NASDAQ-ALGN) designs, manufactures and markets a system of clear aligner therapy for the misalignment of teeth. Last night, the stock was downgraded by Morgan Stanley (NYSE:MS). Today, the stock price is declining sharply lower by 9.58 percent to $250.52 a share. Traders should note that the stock is now trading below the 50-day moving average. This puts the stock in a weak technical position and will usually signal further downside in the near term. The stock will still have very good daily chart support around the $238.50 level. This area is where the stock was defended at the start of April. Please understand, daily chart support levels are usually good for about 3 to 5 trading days.
Nicholas Santiago
InTheMoneyStocks
hedge_fun
13 years ago
ALGN ~ Steps in the Right Direction
Steps in the Right Direction - Featured Research on Align Technology, Inc. and IDEXX Laboratories, Inc.
Today, www.BollingerReport.com introduced featured coverage of Align Technology, Inc. (NASDAQ: ALGN) and IDEXX Laboratories, Inc. (NASDAQ: IDXX).
With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% haircut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.
Bollinger Report screened and selected Align Technology, Inc. for its current position within the healthcare industry. Align Technology, Inc. (Align) designs, manufactures and markets the Invisalign system, a method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a range of appliances, which move teeth to a desired final position. A copy of this report featuring Align Technology, Inc. (NASDAQ: ALGN) is available at: www.BollingerReport.com/index.php?sm1=ALGN.
Bollinger Report is featuring IDEXX Laboratories, Inc. for its changing role within the healthcare industry. IDEXX LABORATORIES, INC. (IDEXX) develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, water testing and dairy markets. It also sells a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. To download researches and analysis on IDEXX Laboratories, Inc. (NASDAQ: IDXX) we welcome investors to visit: www.BollingerReport.com/index.php?sm2=IDXX.
About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.
Contact:
Martin Schwartz
Email Contact
www.BollingerReport.com
hedge_fun
13 years ago
ALGN Executive to Present at NASDAQ OMX Investor Conference
Align Technology, Inc. (Nasdaq:ALGN) today announced that Kenneth Arola, VP of Finance and CFO will speak at an upcoming financial conference. The presentation, as noted below, will be web cast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months.
Conference: NASDAQ OMX 27th Investor Conference, London, England
Date: Tuesday, December 6, 2011
Presentation: 9:00 - 9:30 a.m. GMT
Speaker: Kenneth Arola, Vice President of Finance and CFO
About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. The Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express 10, and Vivera Retainers. To learn more about Invisalign or to find an Invisalign trained doctor in your area, please visit www.invisalign.com.
Cadent Holdings, Inc. is a subsidiary of Align Technology and is a leading provider of 3D digital scanning solutions for orthodontics and dentistry. The Cadent family of products includes iTero and iOC scanning systems, OrthoCAD iCast, OrthoCAD iQ and OrthoCAD iRecord. For additional information, please visit www.cadentinc.com.
CONTACT: Investor Relations Contact
Shirley Stacy
Align Technology, Inc.
(408) 470-1150
sstacy@aligntech.com
Press Contact
Shannon Mangum Henderson
Ethos Communication, Inc.
(678) 261-7803
align@ethoscommunication.com